Published in
Elsevier, Multiple Sclerosis and Related Disorders, (20), p. 93-99
DOI: 10.1016/j.msard.2018.01.011
Links
Tools
Biomarkers identification for PML monitoring, during Natalizumab (Tysabri®) treatment in Relapsing-Remitting Multiple Sclerosis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 